🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2012-03-16
Trial ID
NCT01532089
Treatments Being Tested
The focus of this study is to evaluate whether a new fraud material will be...
Status
Completed
Location
The Southern University
Start Date
2018-04-01
Trial ID
NCT03685292
Treatments Being Tested
This study will test the feasibility of delivering smartphone-based mindful...
Status
Completed
Location
University of Pittsburgh
Start Date
2022-09-01
Trial ID
NCT05516108
Treatments Being Tested
The goal of the study is to conduct a randomized clinical trial to evaluate...
Status
Completed
Location
Ohio University
Start Date
2021-08-12
Trial ID
NCT05137327
Treatments Being Tested
The main purpose of the study is to find out if MBSR (Mindfulness) in addit...
Status
Unknown
Location
Multiple Locations
Start Date
2017-12-01
Trial ID
NCT03271788
Treatments Being Tested
This phase III trial compares the effect of bevacizumab and osimertinib com...
Status
Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-12-28
Trial ID
NCT04181060
Unipolar and bipolar disorder combined account for nearly half of all morbi...
Status
Completed
Location
Psychiatric Center Copenhagen, Rigshospitalet
Start Date
2017-05-15
Trial ID
NCT03033420
This phase II trial tests how well retifanlimab with bevacizumab and hypofr...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-10-02
Trial ID
NCT06160206
This randomized phase III trial studies doxorubicin hydrochloride, cyclopho...
Status
Active Not Recruiting
Location
Northeast Alabama Regional Medical Center
Start Date
2007-11-02
Trial ID
NCT00433511
This phase II/III compares the standard therapy (chemotherapy plus cetuxima...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2023-03-13
Trial ID
NCT05063552